PUBLISHER: Grand View Research | PRODUCT CODE: 1493181
PUBLISHER: Grand View Research | PRODUCT CODE: 1493181
The global cell processing instruments market size is anticipated to reach USD 9.74 billion by 2030 and is projected to grow at a CAGR of 7.04% from 2024-2030, according to a new report by Grand View Research, Inc. The rising incidence of chronic diseases, continuous advancements in cell processing technologies, and the expanding field of stem cell research are anticipated to increase the demand for cell processing instruments over the forecast period.
The COVID-19 pandemic has had a positive impact on the market growth. The pandemic has impelled investments in biopharmaceutical research, including cell-based therapies, driving demand for cell processing instruments. In addition, the increased demand for vaccines and treatments has accelerated the adoption of advanced cell processing technologies, boosting market growth. Moreover, it also highlighted the importance of regenerative medicine and cell therapies in addressing healthcare challenges, further driving interest and investment in this sector.
Moreover, continuous advancements in cell processing technologies, such as automated systems, closed systems, and the integration of robotics, improve efficiency, reduce contamination risks, and enhance the scalability of cell processing, thus driving market growth.
However, cell processing instruments often require a significant upfront investment, along with ongoing maintenance and operational expenses, which can pose a barrier to adoption, especially for smaller research facilities and institutions with limited budgets. Thereby anticipated to hamper the growth of the market to a certain extent.